Refine by
Cancer Research Software
9 software items found
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Maximize your biologically actionable insights from small tumor samples with the SOPHiA DDM™ RNAtarget Technology end-to-end solutions. Gene fusions have been associated with various tumors and are recognized as valuable cancer biomarkers in cancer research1. Targeted RNA sequencing is recommended to maximize novel fusion detection by identifying ...
by:NantOmics based inMorrisville, NORTH CAROLINA (USA)
Evidence-Based Treatment Intelligence for Improved Outcomes in Oncology. Cancer research is ever-evolving. Often, physicians struggle to manage overwhelming amounts of information around the risks, benefits, and trade-offs of different treatment options. Time is of the essence in the world of health care—so when faced with an array of information, ...
by:NantHealth, Inc. based inMorrisville, NORTH CAROLINA (USA)
For clinicians, Eviti Advisor grants access to Eviti’s vast evidence-based treatment library, providing thorough details on the effectiveness, side effects, and cost of potential cancer treatments. Cancer research is ever-evolving. Often, physicians struggle to manage overwhelming amounts of information around the risks, benefits, and ...
by:Inspirata, Inc based inTampa, FLORIDA (USA)
Serving the needs of the entire healthcare institution while providing separate interfaces optimized for each of the two workflows. ...
by:Inspirata, Inc based inTampa, FLORIDA (USA)
NLP-based AI for automated cancer datasets and registry reporting. Inspirata’s E-Path suite of cancer registry automation solutions is powered by an oncology-specific Natural Language Processing (NLP) based artificial intelligence fine-tuned for cancer reporting. While complementing existing workflows, E-Path removes operator variability and far exceeds human performance in adjudicating ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Hematological tumors represent the fourth most frequent cancer type in the developed world. In addition to the continuously evolving clinical guidelines2, harnessing of all the available information when investigating hematological disorders into meaningful insights can be outdated, inaccurate, costly, and time-consuming. This ultimately risks limiting ...
by:Koios Medical, Inc. based inChicago, ILLINOIS (USA)
Cancer diagnosis with ultrasound requires great vision. Koios uses artificial intelligence and machine learning to provide clinical decision support (“DS”) for physicians and technologists when using ultrasound to detect and diagnose cancer. The result: Smart Ultrasound™ Research continues to prove that physician performance and ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Pioneering Innovation, Streamlining Adoption: We are pushing the boundaries of today’s liquid biopsy capabilities. Bring liquid biopsy to your lab with our streamlined DNA-only NGS workflow, taking you from cell-free DNA sample to comprehensive report in record time. Powered by state-of-the-art proprietary algorithms, the SOPHiA DDMTM Platform reveals deep genomic insights from cell-free ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Deeper genomic insights, fewer missed opportunities. CGP enables clinical researchers to identify actionable variants and biomarkers across hundreds of genes using a single solution. The SOPHiA DDMTM Platform offers decentralized, in-house next generation sequencing (NGS) applications that help maximize insights from CGP data by leveraging advanced analytical capabilities, intutive interpretation ...